Abstract Metagenomic sequencing can detect a broad range of pathogens, but interpreting which detections are clinically relevant requires expert adjudication that is difficult to scale and standardize. Here we present diagnostic classifiers that formalize expert adjudication by combining structured decision trees with large language model reasoning to assign diagnoses and select pathogen candidates. We first developed a short-read metagenomic assay for sterile-site specimens (cerebrospinal and ocular fluid) in the META-GP study (Victoria, Australia, 2024-2025) and evaluated classifiers on a validation dataset (n = 96; clinical samples, spike-ins and controls). Locally deployed, open-weight reasoning models (Qwen3) achieved diagnostic performance comparable to expert consensus, improving with clinical context (n = 79, above experimental limit-of-detection; without clinical notes, 94.4% sensitivity, 95.4% specificity; with clinical notes, 97.2% sensitivity, 100% specificity). Automated adjudication enabled systematic benchmarking of computational parameters and regression testing for pathogen detection tasks. In a heterogeneous development cohort (n = 78), reviewers and classifiers identified clinically significant pathogens missed during routine testing. By reproducing consensus detections without requiring a full review panel, diagnostic classifiers enable scalable, standardized metagenomic interpretation that complements expert adjudications.
An autonomous AI agent integrating Reasoning and Acting with Retrieval-Augmented Generation with Retrieval-Augmented Generation is developed to classify 10,211 Human Phenotype Ontology terms, enabling standardized panel design by providing reliable, automated classification supported by direct evidence.
Tohid Ghasemnejad, A. Argha, M. Grosser et al.· 0 citations
STRATUM offers a consequence-tiered model for quality and reporting in applied metagenomics, supporting reproducible, transparent, and defensible sequencing-based surveillance across public health and biodefense domains.
J. A. Russell, I. Keenum, Karen G. Jarvis et al.· Journal of AOAC Internationa...· 0 citations
1Clinical metagenomic sequencing is increasingly used to detect pathogens directly from clinical samples, but sparse and uneven genome recovery caused by low microbial biomass and stochastic fragment loss makes species-level validation difficult. Under these conditions, the same observed coverage may arise either from...
M. Behruznia, F. Silva-Toro, D. A. Márquez· medRxiv· 0 citations
aiDIVA is presented, an ensemble-AI combining statistical and machine learning models trained on genomic and phenotypic data to identify causal variants among tens of thousands per patient, and applies a random forest model to classify pathogenicity and generates evidence-based scores for dominant and recessive disease...
D. Boceck, L. Laugwitz, M. Sturm et al.· npj Genomic Medicine· 1 citation
The rapid deployment of mRNA vaccines during the COVID-19 pandemic exposed limitations in traditional pharmacovigilance systems, including delayed reporting, high underreporting rates, and inability to calculate true incidence. Machine learning (ML) offers new pathways to overcome these challenges by integrating multi-...
Yu-Long He, Yan Mao, Xin-Yue Wang· BMC Medical Informatics and...· 0 citations
Viral metagenomics, leveraging high-throughput sequencing technologies, provides comprehensive, hypothesis-free characterization of viral communities in clinical specimens, establishing itself as a pivotal tool for clinical diagnosis, pathogen discovery, and epidemiological surveillance of viral infectious diseases. Th...
Quan Shen, Wen-Hui Shi, Chao-Ran Liu et al.· Journal of Applied Microbiol...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.